Aethlon Medical (AEMD) Change in Account Payables (2011 - 2026)
Aethlon Medical's (AEMD) quarterly Change in Account Payables came in at -$169596.0 in Q1 2026, up 16.18% YoY from -$145976.7 in Q1 2025, and down 1498.76% on a QoQ basis from -$10608.0 in Q4 2025.
Aethlon Medical (AEMD) Change in Account Payables (2011 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 16 years of Change in Account Payables data on file, last reported at -$169596.0 in Q1 2026.
- Quarterly Change in Account Payables rose 16.18% year-over-year to -$169596.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$511315.0 (down 1643.31% YoY) and the FY2026 annual result came in at -$511315.0, down 1643.31% from the prior year.
- Change in Account Payables slipped to -$169596.0 in Q1 2026, from -$10608.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $406264.0 in Q4 2023 to a low of -$229645.0 in Q4 2024.
- A 5-year average of -$3654.4 and a median of $6303.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables surged 3056.67% — and 2024, when it tumbled 560.09%.
- Tracing AEMD's Change in Account Payables over 5 years: stood at $12870.0 in 2022, then surged by 3056.67% to $406264.0 in 2023, then sank by 156.53% to -$229645.0 in 2024, then surged by 95.38% to -$10608.0 in 2025, then tumbled by 1498.76% to -$169596.0 in 2026.
- The last three Change in Account Payables figures came in at -$169596.0 (Q1 2026), -$10608.0 (Q4 2025), and -$124144.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169,596.00 |
| Mar 31, 2026 | -169,596.00 |
| Dec 31, 2025 | -10,608.00 |
| Dec 31, 2025 | -10,608.00 |
| Sep 30, 2025 | -124,144.00 |
| Sep 30, 2025 | -124,144.00 |
| Jun 30, 2025 | -206,967.00 |
| Jun 30, 2025 | -206,967.00 |
| Mar 31, 2025 | -202,334.00 |
| Mar 31, 2025 | -202,334.00 |
| Dec 31, 2024 | -229,645.00 |
| Dec 31, 2024 | -229,645.00 |
| Sep 30, 2024 | 279,026.00 |
| Sep 30, 2024 | 279,026.00 |
| Jun 30, 2024 | 186,084.00 |
| Jun 30, 2024 | 186,084.00 |
| Mar 31, 2024 | -109,611.00 |
| Mar 31, 2024 | -109,611.00 |
| Dec 31, 2023 | 406,264.00 |
| Dec 31, 2023 | 406,264.00 |